Intellia Therapeutics NTLA
NASDAQ NTLA
$12.26 +0.14 (+1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Price to FCF (2016 - 2017)

Updated

Intellia Therapeutics' (NTLA) Price to FCF came in at 20.46 for Q1 2017, up 110.3% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Price to FCF (2016 - 2017) Analysis & Trends

For FY2016, Intellia Therapeutics' Price to FCF stood at 9.73.

  • According to Business Quant data, Price to FCF for the three prior quarters was 9.73 (Q4 2016), 14.79 (Q3 2016) and 8.92 (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Intellia Therapeutics 1.72 Bn 1.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 20.46
Dec 31, 2016 9.73
Sep 30, 2016 14.79
Jun 30, 2016 8.92
API Access

Intellia Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=NTLA&period=max&api_key=YOUR_API_KEY